Nikki Burdett
Publications by Year
Research Areas
DNA Repair Mechanisms, PARP inhibition in cancer therapy, Cancer Genomics and Diagnostics, Ovarian cancer diagnosis and treatment, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer(2023)83 cited
- → Competing Risks in Older Patients With Cancer: A Systematic Review of Geriatric Oncology Trials(2018)48 cited
- → New biomarkers for checkpoint inhibitor therapy(2020)22 cited
- → Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer(2024)14 cited
- → Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune‐related adverse events after immune checkpoint inhibitor therapy(2019)11 cited
- → Difficulties with assessing the benefit of glucosamine sulphate as a treatment for osteoarthritis(2012)10 cited
- → BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non‐carriers: results from a rapid autopsy programme(2023)6 cited
- → Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer(2023)5 cited
- → Video‐assisted thoracoscopy in the management of intrapleural extravasation of cytotoxic chemotherapy(2017)5 cited
- Targeted therapies, aspects of pharmaceutical and oncological management(2013)